Keywords: Nycomed, Daxas, Veregen, Treatment guidelines, COPD, Genital and perianal warts

Two boosts for Nycomed, as Daxas and Veregen gain treatment guideline backing

Article | 06 January 2011

Print This

Independent Swiss drugmaker has received a couple of pieces of positive news for its products; first yesterday for its genital ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in